Shree Ganesh Biotech Limited has announced its Annual Secretarial Compliance Report for FY 2024-25, audited by KH & Associates.

The report confirms full compliance with applicable SEBI regulations and no instances of non-compliance or regulatory actions during the review period.

Key governance practices such as board performance evaluation, policy adoption, related party transaction approvals, and disclosure norms have been properly followed.

No directors face disqualification, and the company maintains a functional website with timely updates.

This demonstrates Shree Ganesh’s adherence to corporate governance standards, ensuring transparency and regulatory conformity for shareholders.